282 related articles for article (PubMed ID: 25744272)
1. Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy.
Serino G; Sallustio F; Curci C; Cox SN; Pesce F; De Palma G; Schena FP
Nephrol Dial Transplant; 2015 Jul; 30(7):1132-9. PubMed ID: 25744272
[TBL] [Abstract][Full Text] [Related]
2. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
He L; Peng Y; Liu H; Yin W; Chen X; Peng X; Shao J; Liu Y; Liu F
Am J Nephrol; 2013; 38(4):321-32. PubMed ID: 24107646
[TBL] [Abstract][Full Text] [Related]
3. Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients.
Cox SN; Serino G; Sallustio F; Blasi A; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2015 Jul; 30(7):1122-232. PubMed ID: 25770168
[TBL] [Abstract][Full Text] [Related]
4. B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy.
Buck KS; Smith AC; Molyneux K; El-Barbary H; Feehally J; Barratt J
Kidney Int; 2008 May; 73(10):1128-36. PubMed ID: 18322546
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy.
Inoue T; Sugiyama H; Hiki Y; Takiue K; Morinaga H; Kitagawa M; Maeshima Y; Fukushima K; Nishizaki K; Akagi H; Narimatsu Y; Narimatsu H; Makino H
Clin Immunol; 2010 Sep; 136(3):447-55. PubMed ID: 20538527
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
7. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
[TBL] [Abstract][Full Text] [Related]
8. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy.
Qin W; Zhou Q; Yang LC; Li Z; Su BH; Luo H; Fan JM
J Intern Med; 2005 Nov; 258(5):467-77. PubMed ID: 16238683
[TBL] [Abstract][Full Text] [Related]
9. Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2.
Iwasaki H; Zhang Y; Tachibana K; Gotoh M; Kikuchi N; Kwon YD; Togayachi A; Kudo T; Kubota T; Narimatsu H
J Biol Chem; 2003 Feb; 278(8):5613-21. PubMed ID: 12438318
[TBL] [Abstract][Full Text] [Related]
10. TLR9 and BAFF: their expression in patients with IgA nephropathy.
Li W; Peng X; Liu Y; Liu H; Liu F; He L; Liu Y; Zhang F; Guo C; Chen G; Zhang L; Dong Z; Peng Y
Mol Med Rep; 2014 Sep; 10(3):1469-74. PubMed ID: 24993857
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of BAFF in peripheral blood from patients of IgA nephropathy: Correlation with clinical features and Streptococcus pyogenes infection.
Zheng N; Fan J; Wang B; Wang D; Feng P; Yang Q; Yu X
Mol Med Rep; 2017 Apr; 15(4):1925-1935. PubMed ID: 28260100
[TBL] [Abstract][Full Text] [Related]
12. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Namba T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Oka K; Tajiri M; Wada Y; Nonomura N
Biochem Biophys Res Commun; 2019 Jan; 508(4):1106-1112. PubMed ID: 30553446
[TBL] [Abstract][Full Text] [Related]
13. TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.
Zheng N; Xie K; Ye H; Dong Y; Wang B; Luo N; Fan J; Tan J; Chen W; Yu X
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699192
[TBL] [Abstract][Full Text] [Related]
14. External suppression causes the low expression of the Cosmc gene in IgA nephropathy.
Qin W; Zhong X; Fan JM; Zhang YJ; Liu XR; Ma XY
Nephrol Dial Transplant; 2008 May; 23(5):1608-14. PubMed ID: 18202089
[TBL] [Abstract][Full Text] [Related]
15. Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy.
Ji L; Chen X; Zhong X; Li Z; Yang L; Fan J; Tang W; Qin W
BMC Complement Altern Med; 2014 Jun; 14():195. PubMed ID: 24942185
[TBL] [Abstract][Full Text] [Related]
16. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
17. The nucleotide sequence of the IgA1 hinge region in IgA nephropathy.
Greer MR; Barratt J; Harper SJ; Allen AC; Feehally J
Nephrol Dial Transplant; 1998 Aug; 13(8):1980-3. PubMed ID: 9719151
[TBL] [Abstract][Full Text] [Related]
18. GALNT11 as a new molecular marker in chronic lymphocytic leukemia.
Libisch MG; Casás M; Chiribao M; Moreno P; Cayota A; Osinaga E; Oppezzo P; Robello C
Gene; 2014 Jan; 533(1):270-9. PubMed ID: 24076351
[TBL] [Abstract][Full Text] [Related]
19. Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy.
Iwatani H; Inoue T; Wada Y; Nagasawa Y; Yamamoto R; Iijima H; Takehara T; Imai E; Rakugi H; Isaka Y
Biochem Biophys Res Commun; 2012 Nov; 428(3):339-42. PubMed ID: 23098908
[TBL] [Abstract][Full Text] [Related]
20. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
